Lyell Immunopharma (LYEL) Operating Leases (2020 - 2026)
Lyell Immunopharma's Operating Leases came in at $36.93 million for Q2 2026, down 20.7% from $46.6 million a year earlier and down 6.5% from the prior quarter.
Powered by 
Analysis
Lyell Immunopharma (LYEL) Operating Leases (2020 - 2026) Analysis & Trends
At the end of FY2025, Lyell Immunopharma's Operating Leases was $41.92 million, down 17.8% from FY2024.
- Operating Leases has declined in each of the last four years, with a five-year compound annual growth rate of -3.8% (FY2020 to FY2025).
- Going back by year, Operating Leases was $50.99 million in FY2024 (-10.4%), $56.89 million in FY2023 (-9.9%), $63.17 million in FY2022 (-5.2%) and $66.65 million in FY2021 (+30.8%).
- The Q2 2026 figure represents the lowest quarterly Operating Leases in data going back to Q4 2020.
- Year-over-year, Operating Leases has declined for 16 consecutive quarters, with an average decline of 14.8% over the last eight quarters.
- The fastest year-over-year change in Operating Leases over five years came in Q4 2021 (growth of 30.8%), and the weakest in Q2 2026 (a decline of 20.7%).
- Business Quant data shows LYEL's Operating Leases at $39.49 million (Q1 2026), $41.92 million (Q4 2025) and $44.29 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Lyell Immunopharma | 218.22 Mn | -806.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.93 Mn |
| Mar 31, 2026 | 39.49 Mn |
| Dec 31, 2025 | 41.92 Mn |
| Sep 30, 2025 | 44.29 Mn |
| Jun 30, 2025 | 46.60 Mn |
| Mar 31, 2025 | 48.85 Mn |
| Dec 31, 2024 | 50.99 Mn |
| Sep 30, 2024 | 51.44 Mn |
| Jun 30, 2024 | 53.32 Mn |
| Mar 31, 2024 | 55.16 Mn |
| Dec 31, 2023 | 56.89 Mn |
| Sep 30, 2023 | 58.58 Mn |
| Jun 30, 2023 | 60.22 Mn |
| Mar 31, 2023 | 61.83 Mn |
| Dec 31, 2022 | 63.17 Mn |
| Sep 30, 2022 | 64.64 Mn |
| Jun 30, 2022 | 66.07 Mn |
| Mar 31, 2022 | 67.48 Mn |
| Dec 31, 2021 | 66.65 Mn |
| Sep 30, 2021 | 65.68 Mn |
API Access
Lyell Immunopharma Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=LYEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();